Clinical Trial Update: Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluated a behavioral intervention among injection drug users who were uninfected with HIV and Hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: HIV Infections, Hepatitis C | Phase 2, Phase 3 | Status: COMPLETED